Diosgenin|16 Dehydropregnenolone Acetate|4-Androstenedione|Prasterone Acetate |Dehydroepiandrosterone|Pregnenolone|Testosterone|Methandienone|Ethisterone|Norethisterone--Henan Quanxin Medical and Chemical Technology Co., Ltd.

First.Basic situation
    Henan Quanxin medical Technology Co., Ltd. is set up by Shaanxi Quanxin medicine Co., Ltd. and Lingbao Jinda electricity industry Co., Ltd. It is a Share-issuing enterprise. Henan Quanxin medical Technology Co., Ltd. is mainly producing and managing hormone medical intermediates and Hormone medical raw materials two new high-tech enterprise that product take as the leading factor new high-tech enterprise.
    The company lies in Xi'an city in Shaanxi Province, with beautiful environment around, easily accessible. The company covers an area of 43300 square meters, construction is with an area of 10703 square meters, registered capital is 20 million yuan, there are more than 130 workers now, and administrative staff is more than 20 among them, 30 engineers and technicians.
    The company was from May of 2002 to August of 2003; produce the construction in such projects as 100 tons of Diosgenin, 100tons 16-DPA, 30tons downstream products of 16-DPA, etc. per year. October 2002 Diosgenin project go into operation smoothly, August 2003 16-DPA and low reaches products production line project go into operation smoothly.
    The company begins from January of 2004, carry on construction to the project of " production line which produce 16 tons of Testosterone raw materials per year " on the basis of original workshop , fully utilize such infrastructure as already existing water , electricity , vapour ,etc. , has already built up Testosterone series raw materials and formated the workshop now, according to GMP " precise to bake bag " workshop and related quality checkout facility,etc. that requirement design, have possessed the production capacity of 16 tons of serial raw materials medicine in annual output.
    Have already obtained the raw materials medicine "medicines production licence" in January of 2005 (Spironolactone, Testosterone Propionate, Ethisterone, Methyltestosterone, Medroxiprogesteron acetate, Norethisterone ), the company is carrying on the confirmation work of medical trade GMP authentication at present. Here after GMP authentication, the medicine production line project of raw materials will become company's new growth engines, create good economic benefits and social benefit for enterprise. In 2005, between company and U.S.A. intercontinental medicine company both sides that Company reach establish close type strategic partner agreement of cooperation enter the implementing stage, finish the raw materials medicine products FDA of entering the American-European market of our company and COS authentication formality under the care of this company, and underwriting some product. The authentication of GMP, FDA, COS will be far-reaching for development of the company.
Second. The leading product of company:
(1) Hormone medical intermediates:
   The leading products is 16- DPA, designed capacity is the annual output 16- DPA100 ton. 16- The downstream products of DPA are such as Dehydroepiandrosterone , Prasterone Acetate, ?4-Androstenedione and some other series of products to be 30 tons.
(2) Hormone raw materials medicine, variety totally seven, its name and output are:
1.Grand sex hormone: Testosterone Propionate, annual production is 3 tons; Methyltestosterone, the annual production is 3 tons; Testosterone, the annual production is 1 ton.
2.The albumen assimilates hormones: Methandienone, the annual production is 1 ton.
3.Progestational hormone: Ethisterone, the annual production is 3 tons; Norethisterone, the annual production is 2 tons;
4.Diuresis medicine: Spironolactone, the annual production is 3 tons.
5.The advance of technology: Methyltestosterone, Methandienone, Testosterone Propionate, Testosterone series products from ?4- Androstenedione begins, adopts ether craft production, compares with traditional craft , First, has been reduced invest, Second, improves product quality, The third, is the reduction of cost , having improved the accepting rate of the products, The fourth, is the production of Methyltestosterone reduces toxicity, also reduced the influence factor of the climate. Through introduce new technology and improve refined the production of Ethisterone, Norethisterone, Spironolactone, First improve charging rate of product, reduction of cost; Second, has improved the quality of the products; The Third is widen the application ranges of Ethisterone.
    The introduction of 16-DPA and downstream products production technology, has filled in the production blanks of Henan province's steroid body hormone field. Among them " the project producing 100 tons of 16-DPA " per year is regarded as " the industrialization key item of the new and high technology " by the scientific and technological drawing room of Henan province, the project of " production line which produce 30 tons of Dehydroepiandrosterone series products per year " is regarded as " the project of Torch Program in national-level 2003 " by the Ministry of Science and Technology, " 16-DPA ", " Dehydroepiandrosterone " products are regarded as " the new high-tech product " by the scientific and technological drawing room of Henan province, enterprises are regarded as " new high-tech enterprise " of Henan province.
The Third, organization structuring of the company.
01, the board of directors of the company
02, the office
03, Finance Department
04, an economic department
05, equipment department
06, quality testing department
07, supplying department
08, sales department
09, an international trading department
10, the department that protects quality
11, produce the technology department
Fourth, the immediate objective of the company and developing direction
1>, developing direction
    The company takes production and management of 16-DPA and downstream products as the core, base on existing 16-DPA production line and low reaches serial products production line , give play to benefit of the medicine production line of raw materials as soon as possible, realize the rolling development of enterprises. Produce and march towards to the finished product medicine in a situation that intermedia products, raw materials medicine products benefit are steady, form steroid body hormone medicine manufacturing enterprise in a certain influence progressively .
2>, enterprise's authentication The Company has obtained the medicine production licence of raw materials already through ISO- 9001 international quality system authentication at present. In order to improve enterprise's popularity , promote enterprises to sample , obtain and enter entering the card accurately of the international market, the plan is through GMP authentication in 2005, carry on FDA of entering the American-European market , COS authentication at the same time , enter preparation of doing well of international market for the enterprise products.
3>, the open-up of the international market The company has already signed with intercontinental Company of medicine company of U.S.A. the purpose contract of supplying now. Management mode that the company plans to rely mainly on the fact that this opens up the overseas market as the opportunity, form and export with the products progressively.
Fifth, main honor which the company obtains in developing
1. 2002.12.25. The "16- DPA" product is are awarded to "new high-tech product" by Henan province scientific and technological drawing room the Certificate No.: 12-142039;
2. 2002.12.25. The "Dehydroepiandrosterone" product is awarded to "new high-tech product" by Henan province scientific and technological drawing room the Certificate No.: 12-142038;
3. 2003.3. The company is awarded to " the devout unit of China " by China market survey centre;
4. 2003.8.Company confirm " ISO9001 standard quality management system authentication unit " as through " Beijing continent hangxing quality authentication center";
5. 2003.7.The company is regarded as " new and high technology enterprises " by the scientific and technological drawing room of Henan province;
6. 2004.11. "the project of producing 100 tons 16-DPA per year" has passed the confirmation of the scientific and technological drawing room of Henan province;
7. 2005.1.The company has obtained the " medicines production licence ".